Meta-analysis of the clinical value of danshen injection and huangqi injection in liver cirrhosis

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Zhu, Changtai ^a   Cao, Hao ^b   Zhou, Xifa ^a   Dong, Chunlei ^a   Luo, Judong ^a   Zhang, Changsong ^a   Liu, Jinming ^b   Ling, Yang ^a  

^a China   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASCORBIC ACID; ASPARTIC POTASSIUM; BILIRUBIN; COLLAGEN TYPE 4; GANLIXIN; GLUCOSE; HEPATITIS B(E) ANTIGEN; HUANGQI; HYALURONIC ACID; INOSINE; LAMININ; LAMIVUDINE; PLANT MEDICINAL PRODUCT; POTASSIUM CHLORIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PYRIDOXINE; SALVIA MILTIORRHIZA EXTRACT; SERUM ALBUMIN; SILYMARIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BIBLIOGRAPHIC DATABASE; BILIRUBIN BLOOD LEVEL; CHINESE; CHINESE MEDICINE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG DATABASE; DRUG EFFICACY; EMBASE; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALVIA MILTIORRHIZA; SEROCONVERSION; UNSPECIFIED SIDE EFFECT;

EID: 84884264867     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/842824     Document Type: Article

References (41)

1. Dai W. J., Jiang H. C., Advances in gene therapy of liver cirrhosis: a review. World Journal of Gastroenterology 2001 7 1 1 8 2-s2.0-0035113476
2. Bataller R., Brenner D. A., Liver fibrosis. Journal of Clinical Investigation 2005 115 2 209 218 2-s2.0-14944385607 10.1172/JCI200524282
3. Liu J., Fan D., Hepatitis B in China. The Lancet 2007 369 9573 1582 1583 2-s2.0-34248176226 10.1016/S0140-6736(07)60723-5
4. Custer B., Sullivan S. D., Hazlet T. K., Iloeje U., Veenstra D. L., Kowdley K. V., Global epidemiology of hepatitis B virus. Journal of Clinical Gastroenterology 2004 38 10, supplement 3 S158 S168 2-s2.0-20944445480
5. Shen Q., Sun Q. W., Zhang Z., The treatment for 39 cases of cirrhosis with compound Danshen injection and Huangqi injection. Shang Hai Yi Yao 1999 20 4 26 28
6. Chen X., Li X., Liu M., Compound Danshen Huangqi injection treatment for 80 cases of liver fibrosis. Zhong Xi Yi Jie He Gan Bing Za Zhi 2000 10 3 39
7. Cai Y. J., Gao Y. P., Zhang Q. Q., Compound Huangqi Danshen injection in the treatment for 44 cases of liver cirrhosis caused by hepatitis chronic hepatitis. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001 21 7 548 549
8. Zhou C. X., The treatment for 120 cases cirrhosis caused by hepatitis compound with Danshen combined with Huangqi. Xian Dai Zhong Xi Yi Jie He Za Zhi 2002 11 21 2111 2112
9. Liu Y. Q., Han W., Wang Z. J., Li L. X., Gao S. Q., The efficacy of Huangqi combined with Danshen injection in the treatment for liver cirrhosis. Ji Lin Zhong Yi Yao 2002 22 5 15
10. Chen J., Chen Z., Huang X. J., The effect on serum markers reflecting the liver function and liver fibrosis in the treatment for liver cirrhosis with Danshen, Huangqi injection. An Hui Zhong Yi Xue Yuan Xue Bao 2003 22 5 32 34
11. Cai Y., The treatment with Danshen combined with Huangqi injection for 66 cases of liver cirrhosis. Shan Xi Yi Yao Za Zhi 2004 33 4 342 343
12. Wu A. M., Zhang L. M., Tang H., Liver hemodynamics of cirrhosis resulted from hepatitis B liver of the treatment with Danshen and Huangqi injection intravenous infusion. Shi Jie Gan Ran Za Zhi 2006 6 1 40 42
13. Yi S. H., Li Y. F., The treatment with Huangqi injection and Danshen injection for 45 cases of cirrhosis caused by chronic hepatitis. Zhe Jiang Zhong Yi Za Zhi 2007 42 4 243
14. Pen A., Wang Z. Y., Clinical observation on Huangqi injection and Danshen injection in the treatment for 52 cases of patients. Zhongguo Yi Yuan Yao Xue Za Zhi 2010 30 13 1131 1133
15. Liu S. J., Lin W. J., Tu D. J., The treatment for decompensated cirrhosis due to chronic hepatitis B liver with Danshen injection, Huangqi injection combined with lamivudine. Zhongguo Zhong Yi Ji Zhen 2010 19 6 934 935
16. Cheng F., Li Y., Feng L., Li S., Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury. Transplantation Proceedings 2008 40 7 2167 2170 2-s2.0-51249116921 10.1016/j.transproceed.2008. 06.052
17. Arthur M. J. P., Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002 122 5 1525 1528 2-s2.0-0036240890
18. Soriano V., Labarga P., Ruiz-Sancho A., Garcia-Samaniego J., Barreiro P., Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin. AIDS 2006 20 17 2225 2227 2-s2.0-33750586572 10.1097/01.aids.0000247583.38943.95
19. Pei L. Y., Zheng M. C., Liang H. L., Meta-analysis of curative effect of Danshen injection compared with puerarin on coronary heart disease. He Nan Zhong Yi 2008 28 7 91 92
20. Wang X. Q., Zhang Y., Shengmai injection combined with Compound Danshen injection in the treatment for 64 cases of children with acute viral myocarditis. Zhongguo Zhong Yi Ji Zhen 2011 20 7 1184 1185
21. Yang X., Du C. M., The Medofenoxate and Huangqi injection in the treatment for 68 cases of patients with cerebral vascular accident. Si Chuan Zhong Yi 2002 20 1 43
22. Lin H. W., Peng H. Q., Effect of compound Danshen injection on t-PA, PAI and GMP-140 in the patients with acute myocardial infarction. Zhongguo Zhong Yi Ji Zhen 2005 14 7 615 616
23. Ye L. J., Efficacy observation of Danshen injection combined with Shenmai injection in treating chronic hepatitis B. Hai Xia Yao Xue 2012 24 6 181 182
24. Xu Z. H., The application of compound Danshen injection in epidemic hemorrhagic fever. Xin Zhong Yi 1995 15 3 38 39
25. Yang S. L., Li D., Yan J. Y., A large dose of compound Danshen injection in the treatment of 24 cases of patients with acute leukemia complicated with disseminated intravascular coagulation. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000 20 3 226 227
26. Bai Y. L., Therapeutic effect of danshen injection on chronic active hepatitis. Zhong Xi Yi Jie He Za Zhi 1984 4 2 86 87 2-s2.0-0021375180
27. He M., Luo M. L., Chen L. J., System review of Huangqi injection in the treatment for viral myocarditis. Zhongguo Yao Fang 2010 21 48 4570 4575
28. Fu S., Zhang J., Menniti-Ippolito F., Gao X., Galeotti F., Massari M., Hu L., Zhang B., Ferrelli R., Fauci A., Firenzuoli F., Shang H., Guerra R., Raschetti R., Huangqi injection (a traditional chinese patent medicine) for chronic heart failure: a systematic review. PLoS One 2011 6 5 2-s2.0-79955831169 10.1371/journal.pone.0019604 e19604
29. Chao R., Xi Y. M., Jin R. R., The evaluation of clinical efficacy and safety of aplastic anemia in treatment of Huangqi injection. Zhongguo Xun Zheng Yi Xue 2011 11 10 1205 1209
30. Wang S. L., Guo C. L., Clinical efficacy analysis of huangqi injection in the treatment 15 cases of patients with chronic nephritis. Ji Lin Yi Xue 2012 33 30 6549
31. Sun T., Xu H., Xu F., Astragalus injection for hypertensive renal damage: a systematic review. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 929025 10.1155/2012/929025
32. Bai Y. W., Clinical observation of Huangqi injection in treatment of primary nephrotic syndrome. An Hui Yi Xue 2004 25 4 299 300
33. Lin J. R., Deng C., Clinical study of Huangqi injection in the treatment of children with nephrotic syndrome. Shi Zhen Guo Yi Guo Yao 2007 18 1 169 170
34. Li M., Wang W., Xue J., Gu Y., Lin S., Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. Journal of Ethnopharmacology 2011 133 2 412 419 2-s2.0-78651402015 10.1016/j.jep.2010.10. 012
35. Xu J. W., Fu C. M., Advances in the pharmacologics of Salvia miltiorrhiza. Yi Xue Zong Shu 2006 12 23 1467 1469
36. Gu Y., Gu W., Yu S. L., Research progress on pharmacological action of Salvia miltiorrhiza. Ren Shen Yan Jiu 2007 19 1 25 27
37. Liu Y. Z., Ma D. L., Gao J., The protective effects of Huangqi injection on immunological liver injury in mice. Tian Jin Yi Ke Da Xue Xue Bao 2004 10 2 190 191
38. Chen G.-H., Huang W.-F., Progress in pharmacological effects of compositions of Astragalus membranaceus. Zhongguo Xin Yao Za Zhi 2008 17 17 1482 1485 2-s2.0-70350289108
39. Wang Y. J., Quan Q. Z., Ziqin S., Research on the immune effect of Astragalus membranaceus on ICAM-1 expression in liver fibrosis. Zhongguo Lin Chuang Yao Li Xue Yu Zhi 2000 5 1 49 51
40. Sun Z. X., Wang A. P., Dong X. Y., Huangqi injection in the treatment of chronic hepatitis B: analysis of 60 cases. Shan Dong Yi Xue 2001 41 2 38
41. Wen M. L., Han Y., Observation on the clinical safety of Danshen injection. Zhongguo Fang Ji Xue Za Zhi 2012 18 22 322 324